BComments Off on KaloBios: Martin Shkreli Vs. The Rest Of The World
Summary
The share price of troubled bio-tech KBIO exploded last week after Martin Shkreli bought a majority stake.
Shkreli was appointed CEO and secured 13 million dollar in financing.
Shkreli bought KBIO because of a… Read more
